Ameliora Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Sell |
2,377
-820
| -26% | -$431K | 0.45% | 39 |
|
|
2025
Q1 | $2.03M | Sell |
3,197
-44
| -1% | -$27.9K | 0.76% | 32 |
|
|
2024
Q4 | $2.31M | Sell |
3,241
-99
| -3% | -$70.5K | 0.87% | 27 |
|
|
2024
Q3 | $3.51M | Sell |
3,340
-14
| -0.4% | -$14.7K | 1.46% | 20 |
|
|
2024
Q2 | $3.53M | Buy |
3,354
+96
| +3% | +$101K | 1.6% | 23 |
|
|
2024
Q1 | $3.14M | Sell |
3,258
-6
| -0.2% | -$5.78K | 1.42% | 24 |
|
|
2023
Q4 | $2.87M | Buy |
3,264
+111
| +4% | +$97.5K | 1.42% | 22 |
|
|
2023
Q3 | $2.59M | Buy |
3,153
+703
| +29% | +$579K | 1.54% | 22 |
|
|
2023
Q2 | $1.76M | Sell |
2,450
-114
| -4% | -$81.9K | 1.09% | 34 |
|
|
2023
Q1 | $2.11M | Sell |
2,564
-1,163
| -31% | -$956K | 1.23% | 27 |
|
|
2022
Q4 | $2.69M | Buy |
3,727
+1,710
| +85% | +$1.23M | 1.44% | 26 |
|
|
2022
Q3 | $1.47M | Buy |
2,017
+1,960
| +3,439% | +$1.43M | 0.8% | 39 |
|
|
2022
Q2 | $33K | Sell |
57
-3,739
| -98% | -$2.16M | 0.04% | 35 |
|
|
2022
Q1 | $2.44M | Buy |
+3,796
| New | +$2.44M | 1.6% | 13 |
|